PureHealth – Central News Hub

PureHealth Acquires UK’s Largest Private Healthcare Group for $1.2 Billion

Abu Dhabi-based healthcare platform PureHealth is set to acquire the UK’s largest independent hospital operator, Circle Health Group, in a deal valued at $1.2 billion. The move marks PureHealth’s entry into the UK market and is part of the company’s global expansion strategy…reports Asian Lite News

PureHealth, the largest healthcare platform in the Middle East, has inked a groundbreaking agreement to acquire the Circle Health Group, the UK’s foremost independent hospital operator. The acquisition, valued at a staggering $1.2 billion, heralds PureHealth’s entry into the UK healthcare sector.

Circle Health Group will join a prestigious roster of healthcare providers under the PureHealth umbrella, including SEHA – Abu Dhabi Health Services Company, Daman – Nation Health Insurance Co., PureLab (the Gulf Cooperation Council’s largest lab network), Rafed (Group Procurement Organisation), and the Abu Dhabi Stem Cells Centre, renowned for pioneering stem cell research.

With this acquisition, PureHealth reinforces its commitment to delivering world-class medical care on a global scale and establishing new clinical care pathways. The organization seeks to leverage its diverse portfolio of healthcare providers to cater to the evolving needs of patients, investing in scientific innovation and healthcare infrastructure across all assets to ensure access to the highest international quality standards of medical care.

This strategic acquisition signifies PureHealth’s inaugural presence in the UK and forms an integral part of the company’s broader global expansion initiatives. Patients in both the UAE and the UK will enjoy the benefits of the acquisition through an expanded network of healthcare professionals, diversified healthcare provision options, and the sharing of knowledge and expertise between the two regions.

Circle Health Group stands out as the UK’s largest national network of private hospitals, known for its innovative neurological and musculoskeletal rehabilitation services, pathway management services, and the distinction of being the first European healthcare provider to enter the Chinese market. In 2019, Centene Corporation, a leading US healthcare enterprise and Fortune 500 company, invested in Circle Health Group and subsequently acquired the remaining equity interests in July 2021.

As part of the acquisition, PureHealth will gain full control of Circle Health Group’s portfolio, which encompasses specialties such as Orthopaedics, Oncology, Cardiothoracic Surgery, Ophthalmology, Neurosurgery, General Surgery, and state-of-the-art hospitals. This portfolio includes the UK’s first purpose-built, state-of-the-art rehabilitation hospital.

The signing ceremony for this significant acquisition took place in London and was attended by Farhan Malik, Managing Director and Group Chief Executive Officer of PureHealth, as well as Brent Layton, Senior Advisor to Centene Corporation, and Beau Garverick, Senior Vice President of Corporate Development at Centene Corporation.

Hammad Al Ameri, CEO & Managing Director of Alpha Dhabi Holding PJSC, expressed confidence in PureHealth’s growth and success through this acquisition. Farhan Malik, the Group CEO of PureHealth, welcomed Circle Health Group into the PureHealth family and emphasized the mission of driving scientific innovation to enhance the quality and longevity of human life.

Circle Health Group, comprising over 8,200 dedicated employees and 6,500 consultants, operates in more than 60 specialties across over 50 hospitals in the UK. With a record of over two million patient visits annually, the group generates approximately USD 1.3 billion in revenue. Circle Health Group has consistently delivered exceptional healthcare and comprehensive health solutions since its inception in 2004. The group’s growth includes the acquisition of BMI Healthcare, a prestigious and extensive private hospital group in the UK, renowned for excellence.

This acquisition promises to bring a multitude of benefits to both the UAE’s and the UK’s healthcare ecosystems. It will facilitate the exchange of clinical knowledge and the adoption of cutting-edge medical techniques, bolstered by collaboration among medical professionals. Furthermore, it will introduce advanced technologies and a wider range of treatment options for patients in the UAE, reinforcing the UAE’s position as a global leader in providing world-class healthcare.

In 2022, Circle Health Group earned accolades as Private Hospital Group of the Year and was recognized as one of the Top 25 Best Big Companies to Work For. The organization is celebrated for its patient-focused approach and innovative use of robotics, AI, fully digital pathways, and online booking services in healthcare delivery. Notably, 90% of adults in the UK reside within 90 minutes of a Circle Health Group hospital.

PureHealth recently concluded a USD 500 million equity investment in Ardent Health Services, the fourth-largest private healthcare group in the United States, operating across six states. With its global relationships and international reputation, PureHealth aspires to build upon this legacy through the acquisition of Circle Health Group.

Centene Corporation, a Fortune 500-listed company, is dedicated to improving people’s health and wellbeing. It offers fully integrated, high-quality, cost-effective healthcare services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals across the United States.

PureHealth, the largest integrated healthcare group in the Middle East, boasts an extensive network comprising over 25 hospitals, health insurance, more than 160 laboratories, over 100 clinics, and a workforce of over 24,000 employees. Driven by its unwavering commitment to revolutionize healthcare, PureHealth leverages advanced Artificial Intelligence and Machine Learning technologies to redefine health and challenge life spans. Through efficient data management, PureHealth is actively pursuing the ambitious goal of creating a hospital in the cloud. The organization continues to make a profound impact on individuals’ lives in the UAE and beyond, shaping a sustainable and healthier future for generations to come.

ALSO READ-UAE’s New Clean Energy Push In Africa

PureHealth allocates AED 13bln for procurement

The National ICV Program supports the growth and development of the UAE’s national industrial sector and boosting its competitiveness…reports Asian Lite News

PureHealth, the largest integrated healthcare platform in the Middle East, today reinforced its commitment to the National In-Country Value (ICV) Program – one of the key pillars of the national industrial strategy – by announcing a 30% increase in its 10-year commitment to local procurement, taking its total commitment to AED 13 billion by 2032. The announcement took place on the sidelines of the Make it in the Emirates Forum, which was held from 31 May to 1 June at the Abu Dhabi Energy Center.

Last year, PureHealth joined the National ICV Program following a memorandum of understanding (MoU) with the Ministry of Industry and Advanced Technology (MoIAT). During the inaugural Make it in the Emirates Forum in 2022, PureHealth announced it would procure AED 10 billion worth of products from local suppliers, including medicines and medical products. At the second edition of the forum, PureHealth announced a further AED 3 billion for local purchases, bringing the total value of its local procurement commitments to AED 13 billion. The National ICV Program supports the growth and development of the UAE’s national industrial sector and boosting its competitiveness.

His Excellency Omar Al Suwaidi, Undersecretary of the Ministry of Industry and Advanced Technology said: “The National ICV Program, which is among the UAE’s Projects of the 50 and falls under the national industrial strategy, has succeeded in synergizing the ministry and its government and private sector partners in supporting entrepreneurship and innovation across the industrial sector, especially among small and medium-sized enterprises.”

HE Al Suwaidi added: “ICV-certified companies contributed an estimated AED 53 billion to the national economy in 2022. As the initiative continues to empower the industrial sector and boost its performance and sustainability, it redirects higher portions of public and private sector spending into the national economy.”

PureHealth’s announcement contributes to the AED 10 billion of procurement opportunities announced at the second Make it in the Emirates Forum. The additional opportunities build on last year’s AED 110 billion of offtake agreements.

PureHealth will allocate the opportunities across all buckets of its local procurement in Technology and General Services, Medical Consumables and Supplies including diagnostic consumables, gastro and hepatobiliary systems, laboratory storage and packaging, and patient care, and pharmaceuticals.

Farhan Malik, Managing Director and CEO of PureHealth said: “Last year, PureHealth made a commitment to boost its contribution to the In-Country Value Program, which is an important long-term program aimed at building a sustainable and more prosperous future for the UAE. As part of this commitment, we are pleased to announce a 30% increase in our 10-year commitment to procure from local suppliers, raising the total value to AED 13 billion by 2032. ICV is not just a nice-to-have program but a must-have program that brings long-term benefits to participating entities and the government. If you wish to create long-term gains, you need to make long-term commitments.”

Farhan continued: “ICV is critical in healthcare because the sector needs to be resilient and less dependent on external factors. As a national company, PureHealth is committed to playing its part in elevating the healthcare landscape in the UAE whilst actively supporting local healthcare manufacturing capabilities. In line with the vision of our country’s leadership, we aim to make the UAE the healthcare capital of the world by supporting local industries and futureproofing our healthcare systems.”

Farhan added: “We are thankful to MoIAT for creating an ecosystem that facilitates collaboration to build a better economy and sustainable future for all of us. The Make it in the Emirates Forum has once again been an effective initiative that has brought together different sectors, including healthcare, on a common platform to build a sustainable and strong industrial ecosystem. Supporting the local biotech and medtech sectors are key to unlocking the benefits of the Fourth Industrial Revolution.”

Organized by MoIAT, in partnership with the Abu Dhabi Department of Economic Development and ADNOC under the National Strategy for Industry and Advanced Technology, the Make it in the Emirates Forum aims to attract investors to UAE industries and draw manufacturers to set up in the country.

ALSO READ-UAE healthcare sector shines with scientific breakthroughs